United Biotech (P) Limited, India : Pharmaceutical Business

::	Research & Development
::	International Collaboration
::	Business Opportunities
::	Latest Events
::	Divisions At a Glance

:: Press Releases

:: In Licensing

:: Out Licensing

Methylprednisolone Sodium Succinate 1g Vial

Indications :

Neurological Conditions
Multiple Sclerosis, Spinal Cord Injury, Cerebral Injury

Nephrological Conditions
Glomerular Nephritis, Lupus Nephritis

Organ Transplant

Rheumatic Conditions
Acute Gouty Arthritis, Acute Rheumatic Carditis, Psoriatic Arthritis, Rheumatoid Arthritis

Acute Respiratory Distress Syndrome (ARDS)

Dosage :

May be administered by IV or IM injection or by IV infusion. The preferred method for initial
emergency is IV injection.

Usual Doses : 30mg/kg administered IV over atleast 30 minutes. This dose may be repeated every 4-6 hour for 48 hours.

Initial Doses : 10-40mg IV over a period of several minutes. The larger doses may be required for short term management of severe, acute conditions.

In Multiple Sclerosis : 200mg for a week followed by 80mg every other day for one month.

In Renal Transplantation :
- For induction of Immunosuppression : Start with 80-160mg OD for three days followed by oral therapy.

- In treatment of acute rejection : 500 mg upon diagnosis, followed by 500 mg OD for two days.

Acute Spinal Cord Injury : 30 mg/kg bolus followed by 5.4 mg/kg bolus for 24-48 hours.

Prevention of ARDS and Fat Embolism syndrome : 30 mg/kg body weight can be repeated after 6 hours.

Packing :

1 Vial of 1g

Home

Careers

Site map